Moreover, high DCBLD2 expression was correlated with worse survival in KICH, LGG, ACC, KIRC, MESO, COAD, PAAD, STAD, BLCA, GBM, and LUAD patients (p < 0.05, Fig. 5B). Here, DCBLD2 is linked to glioblastoma.